Abstract:[Objective] To investigate association between the time point of sorafenib administered and suppress effect on tumor growth secondary to the increased expression of vascular endothelial growth factor (VEGF).[Methods] Fifty SD rats were performed intrahepatic implantation using tumor tissues from subcutaneous tumors in nude mice which were administered Walker 256 tumor cells.Ten days after the procedure,MR scans were used to choose forty SD rats with successful hepatic tumor transplantation among fifty experimental animals.Then they were randomly divided into four groups:(A,control group) mere injection of vascular endothelial growth factor (VEGF);(B) administration of sorafenib 72 hours prior to VEGF injection;(C) administration of sorafenib together with VEGF injection;(D) administration of sorafenib 72 hours later to VEGF injection.The tumor growth and median survival time of rodents were observed and compared.After each experimental animal died,immunohistochemical (IHC) methods were applied to detect the expression of VEGF in tumors.[Results] Ten days after the administration of sorafenib,MR showed significant growth of hepatic tumors,the tumor size in experiment group were significiant smaller,than control group (5.4 cm) with statistical significance.Median survival time of four groups were (19.6 ± 1.8) d,(31.2 ± 7.0) d,(27.4 ± 4.9) d,and (26.5 ± 4.6) d,respectively,which indicated that animals in sorafenib groups lived longer than those in control group (P ＜ 0.05).Differences can be obseverd in sorafenib groups with statistical significance existing (P ＜ 0.05).Harvest hepatic tumor tissues from dead animals and HE staining as well as IHC examination were performed.The expression of VEGF in four groups were 88.3 ± 13.6,42.8 ± 8.0,71.9 ± 15.7,and 73.6 ± 13.7.There were statistical significance between control group and sorafenib groups.And further in sorafenib groups,the expressions of VEGF also varied greatly.[Conclusion] Sorafenib can extend the survival time,reduce tumor angiogenesis.And we can conclude that administration of sorafenib before the transient increased expression of VEGF offers survival benefits than that after the evaluation of VEGF levels.

Anti-angiogenesis Effectiveness of VEGF Antisense Oligodeoxynucleotide Loaded Polylactic-Co-glycolic Acid Nanoparticles in the Treatment of Walker-256 Hepatoma in Rats

Role of VEGF in establishment of Walker-256 transplanted liver cancer model in SD rats

Study of the Anti-Tumor Effect of Anti-Vascular Endothelial Growth Factor McAb 5-Fluorouracil Loaded Polylactic Acid Nanoparticles

Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.

[Effects of Vascular Endothelial Growth Factor (VEGF) Antisense Oligodeoxynucleotide on Mrna and Expression of VEGF, Flt-1, and Kinase Insert Domain Containing Receptor and VEGF Excretion in Human Gallbladder Carcinoma Cells].

Angiogenesis Effect on Rat Liver after Administration of Expression Vector Encoding Vascular Endothelial Growth Factor D

Inhibition of angiogenesis in cancer by iNOS antisense oligodeoxynucleotide

Effect of Sorafenib in Increased VEGF in Stimulating Effect of Walker-256 Transplanted Liver Cancer Model in SD Rats

Effect of Antisense Oligodeoxynucleotide of Vascular Endothelial Growth Factor C on Lymphangiogenesis and Angiogenesis of Pancreatic Cancer

Enhanced Antitumor Efficacy on Hepatoma-Bearing Rats with Adriamycin-Loaded Nanoparticles Administered into Hepatic Artery

Inhibitory Effect of Combined Angiogenesis Inhibitor YH-16 with Chemoembolization on Rat's Transplanted Hepatoma

Vascular Endothelial Growth Factor Accelerates Establishment of a Model of Hepatic Metastasis in Walker-256 Tumor-Bearing Rats

Metronidazol Amino Acid Augments Effects of Hepatic Arterial Occlusion Combined with Radiotherapy in a Rat Liver Tumor Model

The suppressing effects of VEGF-mediated angiogenesis at different administration sequences of apatinib and transarterial embolization in vivo

Antiangiogenesis and Damaging Blood Flow by Antisense Vascular Endothelial Growth Factor Oligodeoxynucleotides to Suppress Lung Cancers

Effects of Antisense Oligonucleotides of VEGF-C on Anti-Lymphangiogenesis in Nude Mice with Orthotopic Implantation of Lung Cancer

A Novel Strategy for Locally Deliver VEGF by Nanofiber Mesh for Improving Liver Regeneration

Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP

Prevention and treatment of B16 melanoma by adeno-associated virus-mediated human angiostatin(K1-5) gene transfection

Effect of VEGF-C Antisense Oligodeoxyribonucleotide on Lymphatic Metastasis of Human Breast Cancer

Effect of AAV-AS and cytoxan on subcutaneous glioma in rats